3
Announcements
Trials
Browse
Landscape
Sponsor
Interventions
fludarabine
9
Specimen Handling
9
ruxolitinib
8
Whole-Body Irradiation
8
Azacitidine
8
fludarabine phosphate
7
Biopsy
7
Mycophenolic Acid
6
Cytarabine
6
Cyclophosphamide
6
Busulfan
6
venetoclax
5
Stem Cell Transplantation
5
Injections
5
Tacrolimus
4
Sirolimus
4
Granulocyte Colony-Stimulating Factor
4
CPX-351
4
decitabine and cedazuridine drug combination
3
Thiotepa
3
Peripheral Blood Stem Cell Transplantation
3
Melphalan
3
Liposomes
3
Daunorubicin
3
Cyclosporins
3
Cyclosporine
3
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
3
nilotinib
2
luspatercept
2
ivosidenib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myeloproliferative Disorders
×
Microarray Analysis
×
90 days
×
Clear all
No trials found.